Adeno-associated viral vector-mediated hypoxia response element-regulated gene expression in mouse ischemic heart model
about
Gene therapy for ischemic heart diseaseGut mucosal healing: is the science relevant?[Retroviral reporter systems for the assessment of activity of stress-induced signal transduction pathways controlled by p53, HIF-1 and HSF-1 transcription factors].A novel chimeric promoter that is highly responsive to hypoxia and metals.Adeno associated viral vector-delivered and hypoxia response element-regulated CD151 expression in ischemic rat heart.ESTROGEN REPLACEMENT THERAPY FOR STROKE.IL-15: a novel prosurvival signaling pathway in cardiomyocytes.Sca-1+ cardiosphere-derived cells are enriched for Isl1-expressing cardiac precursors and improve cardiac function after myocardial injuryTreatment of mouse limb ischemia with an integrative hypoxia-responsive vector expressing the vascular endothelial growth factor gene.Coexpression of VEGF and angiopoietin-1 promotes angiogenesis and cardiomyocyte proliferation reduces apoptosis in porcine myocardial infarction (MI) heart.Tumor-specific gene expression using the survivin promoter is further increased by hypoxiaAAV vectors for cardiac gene transfer: experimental tools and clinical opportunities.Construction of PR39 recombinant AAV under control of the HRE promoter and the effect of recombinant AAV on gene therapy of ischemic heart disease.New strategies for cardiovascular gene therapy: regulatable pre-emptive expression of pro-angiogenic and antioxidant genesIntravenous delivery of adeno-associated viral vector serotype 9 mediates effective gene expression in ischemic stroke lesion and brain angiogenic fociHypoxic adaptation engages the CBP/CREST-induced coactivator complex of Creb-HIF-1α in transactivating murine neuroblastic glucose transporter.Permanent coronary artery occlusion: cardiovascular MR imaging is platform for percutaneous transendocardial delivery and assessment of gene therapy in canine modelAn emerging adeno-associated viral vector pipeline for cardiac gene therapyCell survival and redistribution after transplantation into damaged myocardium.Hypoxia-regulated therapeutic gene as a preemptive treatment strategy against ischemia/reperfusion tissue injury.Adeno-associated viral vector delivers cardiac-specific and hypoxia-inducible VEGF expression in ischemic mouse heartsMolecular cardiology in translation: gene, cell and chemical-based experimental therapeutics for the failing heart.Drug delivery systems for the treatment of ischemic stroke.Therapeutic potential of genes in cardiac repair.Redox signaling in cardiac renewal.Functional polymers of gene delivery for treatment of myocardial infarct.AAV-mediated gene therapy for atherosclerosis.Promise of adeno-associated virus as a gene therapy vector for cardiovascular diseases.Non-invasive bioluminescence imaging of myoblast-mediated hypoxia-inducible factor-1 alpha gene transferRobust hypoxia-selective regulation of a retinal pigment epithelium-specific adeno-associated virus vectorA novel adenoviral vector which mediates hypoxia-inducible gene expression selectively in neurons.Virus-based reporter systems for monitoring transcriptional activity of hypoxia-inducible factor 1.Discovery of a novel control element within the 5'-untranslated region of the vascular endothelial growth factor. Regulation of expression using sense oligonucleotides.Hypoxia-controlled matrix metalloproteinase-9 hyperexpression promotes behavioral recovery after ischemia.Hypoxia decreases creatine uptake in cardiomyocytes, while creatine supplementation enhances HIF activation.Adeno-associated viral vector-mediated hypoxia-regulated VEGF gene transfer promotes angiogenesis following focal cerebral ischemia in mice.Assembly PCR synthesis of optimally designed, compact, multi-responsive promoters suited to gene therapy application.Gene delivery of hypoxia-inducible VEGF targeting collagen effectively improves cardiac function after myocardial infarctionLong-term restitution of 4-aminopyridine-sensitive currents in Kv1DN ventricular myocytes using adeno-associated virus-mediated delivery of Kv1.5.Adeno-associated virus vectors simultaneously encoding VEGF and angiopoietin-1 enhances neovascularization in ischemic rabbit hind-limbs.
P2860
Q24632135-71237613-66A6-43C9-8EC2-6C1342F2637FQ24669693-9E6A20CD-DACE-4A15-BF87-A66E7D391E5AQ31164417-22DEE7C3-AAC8-41AC-B192-EABF6511A53EQ33233475-0744A197-0984-4A38-B626-BF704DC9674CQ33565700-D1B4A455-2E08-4940-8F26-AA4114372B63Q33840436-53AFD142-6F3A-4A73-AEB0-A7F5CFBE5F69Q33972581-A15E104C-4764-465F-9719-290F0352B872Q34137691-BD58F355-495B-41F0-A9E7-42FDCD01839BQ34217612-C1675451-B0A5-4FF3-BFDD-EDBA09FCFEA8Q34550233-F3D83AD2-F124-4CA3-95D6-1693709D6040Q35184871-BB3C3C21-BD8F-4757-8348-7668BA429198Q35238264-11B33405-DEE4-4995-96B4-F2E4A691C598Q36385119-C379FA59-8BDC-4603-BE0C-CC2E68F30D84Q36385632-B5E55CC2-9D08-4359-AC3E-F9E745E61284Q36493030-AA49EB6D-3ABD-4793-8737-A5ED56F745BBQ36699753-4AAE3407-C40E-4C13-9693-F3D5B93A04FDQ37133859-D3D1C98F-540E-467D-9A82-BBC4BA6F5346Q37272838-12FC75F3-37BE-4195-989A-B4AFBEA5FD11Q37294348-1890D117-C155-4E73-A922-883885444B49Q37484960-464AE14A-D403-480F-9D60-F40B4639B196Q37610441-BAF5297A-CF41-4DD7-B4D3-76C6BA47048FQ37643467-38840E80-9A51-4788-A664-033C86AFBB69Q38073181-A76EDD08-F57B-4DA0-921F-903F84C43F8FQ38128924-FD5DCB9E-DFFB-41E2-8F84-8690B011134EQ38226891-CC3C718C-D560-4015-BE57-E0CFEF86BF47Q38235326-895BBE83-7B4A-4C0E-8658-B722C4A0F0E5Q38236204-142AC4E4-1EE0-4619-AAAE-40ADB1F88783Q39356341-BC6EBDF9-023C-4DE7-8896-B33D8135A316Q39602637-62CBDD85-52E5-4FA0-91BC-F767EBD93A27Q40003426-1D6D6550-40BE-4A6D-B18E-069962589586Q40432513-509F8F66-3E9E-46FC-8FE3-159E89DBCA4BQ40442087-F7C3D4CB-F635-4DC9-8788-BF6531493C1CQ40542288-07067C2A-AF9E-4103-B0D5-993C96B8CE46Q41465196-E5392481-350C-4CF6-BD5D-FC470E1AEABAQ41600066-D02F318C-C50C-48AD-B708-0E4CDA88AF70Q41675111-B9D27F9E-8F2B-464D-8336-AD81FFDEDCCDQ42084870-5D3D6D8C-56DE-427C-A0DD-BF89B31DB1ADQ42378908-7258D6D9-010E-4CE6-97B8-251F432E3441Q44560485-51CE2CB5-E433-4BDA-9535-93ADB8D9CD2DQ45406014-F19576D4-3FBA-4994-81CF-45E6DFD17E83
P2860
Adeno-associated viral vector-mediated hypoxia response element-regulated gene expression in mouse ischemic heart model
description
2002 nî lūn-bûn
@nan
2002 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2002 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2002年の論文
@ja
2002年論文
@yue
2002年論文
@zh-hant
2002年論文
@zh-hk
2002年論文
@zh-mo
2002年論文
@zh-tw
2002年论文
@wuu
name
Adeno-associated viral vector- ...... in mouse ischemic heart model
@ast
Adeno-associated viral vector- ...... in mouse ischemic heart model
@en
Adeno-associated viral vector- ...... in mouse ischemic heart model
@nl
type
label
Adeno-associated viral vector- ...... in mouse ischemic heart model
@ast
Adeno-associated viral vector- ...... in mouse ischemic heart model
@en
Adeno-associated viral vector- ...... in mouse ischemic heart model
@nl
prefLabel
Adeno-associated viral vector- ...... in mouse ischemic heart model
@ast
Adeno-associated viral vector- ...... in mouse ischemic heart model
@en
Adeno-associated viral vector- ...... in mouse ischemic heart model
@nl
P2093
P2860
P356
P1476
Adeno-associated viral vector- ...... in mouse ischemic heart model
@en
P2093
Janice Arakawa-Hoyt
Yuet Wai Kan
P2860
P304
P356
10.1073/PNAS.132275299
P407
P577
2002-06-25T00:00:00Z